Dr. Jason Rich, M.D.
Claim this profileWashington University School of Medicine
Area of expertise
Squamous Cell Carcinoma
Jason Rich, M.D. has run 3 trials for Squamous Cell Carcinoma. Some of their research focus areas include:
Head And Neck Cancers
Jason Rich, M.D. has run 2 trials for Head and Neck Cancers. Some of their research focus areas include:
Affiliated Hospitals
Washington University School Of Medicine
Clinical Trials Jason Rich, M.D. is currently running
Radiation, Cisplatin, and Surgery
for Throat Cancer
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer. Oropharynx SCC (OPSCC) is a common sub-type of HNSCC. Each year, 16,000 new cases of OPSCC are diagnosed in the USA. Most cases of OPSCC (\>90%) are caused by the human papillomavirus (HPV) and are often cured with current therapy. However, patients treated with surgery followed by postoperative adjuvant chemotherapy and radiation therapy (POA(C)RT) still experience substantial morbidity. In this highly curable disease, current clinical research interest is focused on investigation of de-escalated therapy, with the goal to reduce treatment-related adverse events (AEs) while maintaining a low recurrence rate. In this study, patients with HPV-related OPSCC will undergo resection of the primary tumor site and involved/at-risk regional neck nodes. Based on the pathology report, patients will be assigned to: * Arm 1 (de-POACRT-42 Gy) * Arm 2A (de-POART-42 Gy) * Arm 2B (de-POART-37.8 Gy) * Arm 2C (de-POACRT-30 Gy). All patients with high-risk pathology will be assigned to Arm 1 whereas patients with intermediate-risk pathology will be randomized (1:1:1) to Arm 2A, Arm 2B, or Arm 2C. Patients with highest-risk pathology and low-risk pathology will be removed from the trial after surgery and will be advised to pursue standard of care options.
Recruiting
1 award
Phase 2
6 criteria
CUE-101
for Throat Cancer
This trial tests a new treatment called CUE-101 to see if it is safe and effective for patients with a specific type of throat cancer. The treatment aims to boost the immune system before standard cancer therapy. Patients are newly diagnosed and have not yet received any other treatments.
Recruiting
1 award
Phase 2
More about Jason Rich, M.D.
Clinical Trial Related
7 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Jason Rich, M.D. has experience with
- Cisplatin
- Radiation Therapy
- CareOrbit
- Cetuximab
- Intensity-Modulated Radiation Therapy
- Palbociclib
Breakdown of trials Jason Rich, M.D. has run
Squamous Cell Carcinoma
Head and Neck Cancers
Head and Neck Squamous Cell Carcinoma
Oropharyngeal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jason Rich, M.D. specialize in?
Jason Rich, M.D. focuses on Squamous Cell Carcinoma and Head and Neck Cancers. In particular, much of their work with Squamous Cell Carcinoma has involved Stage III patients, or patients who are p16 positive.
Is Jason Rich, M.D. currently recruiting for clinical trials?
Yes, Jason Rich, M.D. is currently recruiting for 2 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Jason Rich, M.D. has studied deeply?
Yes, Jason Rich, M.D. has studied treatments such as Cisplatin, Radiation therapy, CareOrbit.
What is the best way to schedule an appointment with Jason Rich, M.D.?
Apply for one of the trials that Jason Rich, M.D. is conducting.
What is the office address of Jason Rich, M.D.?
The office of Jason Rich, M.D. is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.